Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-03-29 @ 6:20 AM
Study NCT ID:
NCT07206758
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2025-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SHR-2173-105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None